key: cord-0023431-rqq3pys5
authors: Schamberger, Barbara; Plaetzer, Kristjan
title: Photofungizides Based on Curcumin and Derivates Thereof against Candida albicans and Aspergillus niger
date: 2021-10-28
journal: Antibiotics (Basel)
DOI: 10.3390/antibiotics10111315
sha: bef99575ee3632141e6c483267c6c9d45cf3d089
doc_id: 23431
cord_uid: rqq3pys5

Fungal infections in humans, contamination of food and structural damage to buildings by fungi are associated with high costs for the general public. In addition, the increase in antifungal resistance towards conventional treatment raises the demand for new fungicidal methods. Here, we present the antifungal use of Photodynamic Inactivation (PDI) based on the natural photosensitizer curcumin and a water-soluble positively charged derivative thereof (SA-CUR 12a) against two different model organisms; Candida albicans grown in a liquid culture and photo treated with a 435 nm LED light followed by counting of the colony-forming units and photoinactivation of tissue-like hyphal spheres of Aspergillus niger (diameter ~5 mm) with subsequent monitoring of colony growth. Curcumin (50 µM, no incubation period, i.p.) supplemented with 10% or 0.5% DMSO as well as SA-CUR 12a (50 µM no i.p or 5 min i.p.) triggered a photoantifungal effect of >4 log units towards C. albicans. At 100 µM, SA-CUR 12a (0 min or 5 min i.p.) achieved a reduction of >6 log units. Colonies of A. niger shrunk significantly during PDI treatment. Photoinactivation with 50 µM or 100 µM curcumin (+0.5% DMSO) resulted in complete growth inhibition. PDI using 20, 50 or 100 µM SA-CUR 12a (with or without 10% DMSO) also showed a significant reduction in colony area compared to the control after 48 h, although less pronounced compared to curcumin. In summary, PDI using curcumin or SA-CUR 12a against C. albicans or A. niger is a promising alternative to currently used fungicides, with the advantage of being very unlikely to induce resistance.

From the kingdom of fungi, about 600 species are known to be human pathogens, that can be potentially harmful to immunocompromised people (e.g., Candida spp. or Aspergillus spp.) [1] . As the number of immuno-deficient people increases due to the rising number of patients undergoing cancer therapy, organ recipients or people treated for human immunodeficiency virus, the risk of contracting a fungal infection also increases [2] [3] [4] . In addition, an increase in antimicrobial resistance is observed in recent years [5] . Fungi in the form of mold in buildings cause high costs as well as an increased health risk for the occupants [6] . Therefore, new antifungal agents are needed to counter the increasing number of fungal infections and the increasing antifungal resistance against conventional agents [5] .

Photodynamic Inactivation (PDI), also known as Antimicrobial Photodynamic Therapy, is a method that was shown to be highly effective against bacteria [7] [8] [9] [10] [11] [12] . PDI uses a photoactive substance, or photosensitizer (PS), which, together with oxygen and excitation by light of an appropriate wavelength, generates reactive oxygen species (ROS) [13] . Unlike antibiotics, PDI is not linked to a specific target in the organism, which is why the development of resistance to PDI is unlikely but must still be considered [14, 15] . Two Curcumin dissolved with 0.5% DMSO showed an antimicrobial effect (reductio 3 log) of 2.6 × 10 4 only in the concentration 50 µM without incubation period (i. p.) be illumination. Using a five-minute incubation with the PS before illumination resulted decrease in relative inactivation (rel. inactivation 4.0 × 10 2 ), which was even m pronounced (rel. inactivation 5.5 × 10 1 ), if the incubation period was extended to 25 m After increasing the concentration of supplemented DMSO to 10% ( Figure 2 ) antimycotic effect of 50 µM curcumin and no incubation before illumination was in same order of magnitude (rel. inactivation 4.7 × 10 4 ) as for the lower concentratio DMSO. The effect of the treatments with 50 µM curcumin and incubation times of 5 (rel. inactivation 1.8 × 10 4 ) or 25 min (rel. inactivation 4.3 × 10 3 ) lead to lower efficie but the effect still remains above 3 log. Lower concentrations (5, 10 and 20 µM curcumin with 10% DMSO induced no antimicrobial effect. Curcumin dissolved with 0.5% DMSO showed an antimicrobial effect (reduction of 3 log) of 2.6 × 10 4 only in the concentration 50 µM without incubation period (i. p.) before illumination. Using a five-minute incubation with the PS before illumination resulted in a decrease in relative inactivation (rel. inactivation 4.0 × 10 2 ), which was even more pronounced (rel. inactivation 5.5 × 10 1 ), if the incubation period was extended to 25 min.

After increasing the concentration of supplemented DMSO to 10% ( Figure 2 ) the antimycotic effect of 50 µM curcumin and no incubation before illumination was in the same order of magnitude (rel. inactivation 4.7 × 10 4 ) as for the lower concentration of DMSO. The effect of the treatments with 50 µM curcumin and incubation times of 5 min (rel. inactivation 1.8 × 10 4 ) or 25 min (rel. inactivation 4.3 × 10 3 ) lead to lower efficiency, but the effect still remains above 3 log. Lower concentrations (5, 10 and 20 µM) of curcumin with 10% DMSO induced no antimicrobial effect.

Photodynamic Inactivation based on the water-soluble cationic SA-CUR 12a at concentrations of 50 µM without incubation induced an antimycotic effect (3.3 × 10 4 ) comparable to 50 µM curcumin without incubation. Increasing the incubation time (i.p. 5 min) slightly increased the effect to 9.5 × 10 4 . A 25 min incubation showed no improvement but led to a drop in efficiency below the 3 log criteria to a relative inactivation of 7.5 × 10 2 . Increasing the concentration of SA-CUR 12a to 100 µM and incubation for 5 or 25 min prior to illumination resulted in a pronounced decimation of viable C. albicans of at least 1.6 × 10 6 , which was at the detection limit ( Figure 3 ). Photodynamic Inactivation based on the water-soluble cationic SA-CUR 12a at concentrations of 50 µM without incubation induced an antimycotic effect (3.3 × 10 4 ) comparable to 50 µM curcumin without incubation. Increasing the incubation time (i.p. 5 min) slightly increased the effect to 9.5 × 10 4 . A 25 min incubation showed no improvement but led to a drop in efficiency below the 3 log criteria to a relative inactivation of 7.5 × 10 2 . Increasing the concentration of SA-CUR 12a to 100 µM and incubation for 5 or 25 min prior to illumination resulted in a pronounced decimation of viable C. albicans of at least 1.6 × 10 6 , which was at the detection limit ( Figure 3 ). 

To determine whether PDI treatment leads to a loss of the cell mass immediately after illumination the colony areas of the A. niger mycelial patches were measured before and directly after illumination. Figure 4 displays the diameters of mycelial patches (i.e., colony areas) of A. niger photo treated with PS as well as the control groups (C-/-, light only, PS only) before and after illumination. A significant decrease in patch size is seen post- 

To determine whether PDI treatment leads to a loss of the cell mass immediately after illumination the colony areas of the A. niger mycelial patches were measured before and directly after illumination. Figure 4 displays the diameters of mycelial patches (i.e., colony areas) of A. niger photo treated with PS as well as the control groups (C−/−, light only, PS only) before and after illumination. A significant decrease in patch size is seen post-treatment. The list of samples included in each group can be found in the Appendix A. After incubating the samples at growth conditions for 48 h post-treatment it can seen that the control sample developed black spores, while the development slows do in the samples treated with 100 µM SA-CUR12a and after 48 h there are fewer or no spo ( Figure 5 ). In colonies treated with 100 µM curcumin + 0.5% DMSO, growth w completely inhibited and no new mycelium was formed. . Colony area of mycelial patches of A. niger before and after treatment. The plot shows the median and the standard deviation of the colony area. Statistical significance of the area before and after treatment is indicated with no significance (n. s.), p < 0.001 (***). n control = 33, n treatment = 60.

After incubating the samples at growth conditions for 48 h post-treatment it can be seen that the control sample developed black spores, while the development slows down in the samples treated with 100 µM SA-CUR12a and after 48 h there are fewer or no spores ( Figure 5 ). In colonies treated with 100 µM curcumin + 0.5% DMSO, growth was completely inhibited and no new mycelium was formed.

Looking at the growth of the colonies after treatment over time, it can be seen that the control samples C−/− and light only show a similar growth behavior: the PS control (curcumin + 0.5% DMSO) without illumination already reduced growth rate. Using at least 50 µM of curcumin with 0.5% DMSO, the growth was completely suppressed. Lower concentrations of curcumin (10 µM, 20 µM + 0.5% DMSO) still resulted in a significant difference in the grown area after 48 h ( Figure 6 ).

The cationic SA-CUR 12a did not induce any dark toxicity ( Figure 7 ). The highest phototoxicity of SA-CUR 12a was observed at a concentration of 100 µM with a mean colony area after 48 h of 3.0 mm 2 . At lower concentrations, the photoantimycotic effect was less pronounced with decreasing concentration of SA-CUR 12a. After incubating the samples at growth conditions for 48 h post-treatment it can be seen that the control sample developed black spores, while the development slows down in the samples treated with 100 µM SA-CUR12a and after 48 h there are fewer or no spores ( Figure 5 ). In colonies treated with 100 µM curcumin + 0.5% DMSO, growth was completely inhibited and no new mycelium was formed. Looking at the growth of the colonies after treatment over time, it can be seen that the control samples C-/-and light only show a similar growth behavior: the PS control (curcumin + 0.5% DMSO) without illumination already reduced growth rate. Using at least 50 µM of curcumin with 0.5% DMSO, the growth was completely suppressed. Lower concentrations of curcumin (10 µM, 20 µM + 0.5% DMSO) still resulted in a significant difference in the grown area after 48 h ( Figure 6 ). The cationic SA-CUR 12a did not induce any dark toxicity (Figure 7) . The highest phototoxicity of SA-CUR 12a was observed at a concentration of 100 µM with a mean colony area after 48 h of 3.0 mm². At lower concentrations, the photoantimycotic effect was less pronounced with decreasing concentration of SA-CUR 12a.

To examine whether the phototoxicity of SA-CUR 12a can be increased with DMSO, experiments with 10% of this permeability enhancer were performed. For SA-CUR 12a with 10% DMSO, the highest antimicrobial effect of SA-CUR 12a was achieved with 100 µM (mean colony area after 48 h of 3.4 mm², see Figure 8 ). Figure 9 summarizes the colony areas of A. niger 48 h post-treatment. Curcumin in combination with DMSO induces significant (p < 0.05) dark toxicity. The individual treatments do all show a significant decrease in the colony area when compared to C-/-. The lowest effect is seen with 20 µM SA-CUR 12a and the highest with curcumin with 10% DMSO at the concentrations 50 µM and 100 µM, inducing complete growth To examine whether the phototoxicity of SA-CUR 12a can be increased with DMSO, experiments with 10% of this permeability enhancer were performed. For SA-CUR 12a with 10% DMSO, the highest antimicrobial effect of SA-CUR 12a was achieved with 100 µM (mean colony area after 48 h of 3.4 mm 2 , see Figure 8 ). 

Fungal infections in humans as well as fungal contamination of buildings or in foo causes high costs for society [6, 32] . In the medical sector, there are only a small number substances approved for the treatment of fungal infection, with the drawback of havin the potential to develop an antimicrobial resistance [5] . Indeed, the resistance of Candid against fluconazole is increasing alarmingly: Since the discovery of multidrug-resistan Candida spp. C. auris in Japan, outbreaks were detected in hospitals in several countrie around the globe [33] . The majority (>90%) of C. auris isolates are resistant to fluconazol an anti-fungal drug widely used in hospitals [17] . This is of particular concern as th availability of approved antifungal treatments is very limited [5] .

In the case of fungal infestation, e.g., mold in buildings, some of the agents used a harmful to the inhabitants [22] . Conventional chemical disinfectants to combat fungi ofte contain bleach, which is a highly reactive substance, or ethanol, which is easily flammabl While bleach is effective against fungi, it also poses a health risk to the user as it can irrita the skin and respiratory tract. Therefore the use of these two substances should therefo be restricted to ventilated rooms [34] . Due to the aforementioned disadvantages conventional antifungal agents, this study focuses on the use of PDI against two fung species with different growth behavior.

PDI using curcumin or curcumin formulations was previously proven to be high efficient against bacteria [24, 26] . In addition, PDI also has the potential to be used again other microbial targets, such as viruses, parasites or even fungi [8] . Due to their relevanc Figure 9 . Summary of phototoxicity of SA-CUR-12a (red) and curcumin (green) in different concentrations and different supplementation of DMSO against A. niger. The incubation period before illumination was 20 min. The plotted colony area was determined after 48 h post-treatment. Illumination was performed with 15.8 J cm −2 /435 nm. Plotted is the mean and standard deviation (n = 9). Statistical significance between individual treatments and C−/− was indicated with p < 0.05 (*), p < 0.005 (**), p < 0.001 (***).

Fungal infections in humans as well as fungal contamination of buildings or in food causes high costs for society [6, 32] . In the medical sector, there are only a small number of substances approved for the treatment of fungal infection, with the drawback of having the potential to develop an antimicrobial resistance [5] . Indeed, the resistance of Candida against fluconazole is increasing alarmingly: Since the discovery of multidrug-resistant Candida spp. C. auris in Japan, outbreaks were detected in hospitals in several countries around the globe [33] . The majority (>90%) of C. auris isolates are resistant to fluconazole, an anti-fungal drug widely used in hospitals [17] . This is of particular concern as the availability of approved antifungal treatments is very limited [5] .

In the case of fungal infestation, e.g., mold in buildings, some of the agents used are harmful to the inhabitants [22] . Conventional chemical disinfectants to combat fungi often contain bleach, which is a highly reactive substance, or ethanol, which is easily flammable. While bleach is effective against fungi, it also poses a health risk to the user as it can irritate the skin and respiratory tract. Therefore the use of these two substances should therefore be restricted to ventilated rooms [34] . Due to the aforementioned disadvantages Antibiotics 2021, 10, 1315 9 of 14 of conventional antifungal agents, this study focuses on the use of PDI against two fungal species with different growth behavior. PDI using curcumin or curcumin formulations was previously proven to be highly efficient against bacteria [24, 26] . In addition, PDI also has the potential to be used against other microbial targets, such as viruses, parasites or even fungi [8] . Due to their relevance in many aspects, more and more research is looking into the potential of PDI to combat fungi [28, [35] [36] [37] [38] . Therefore, we have shown here that PDI using curcumin and a water-soluble derivate of curcumin (SA-CUR 12a) shows potential as an alternative to conventional treatment.

To demonstrate the potential of the photoantifungal approach for clinical application, C. albicans was used as a model organism. Although 50 µM curcumin with 10% DMSO (i.p. 0 ) showed an antimicrobial effect of 4.7 log steps, the efficiency is lower when compared to the phototoxicity reported by Dovigo and coworkers [28] . In this study, the authors showed complete eradication (~6 log) of C. albicans using lower curcumin concentrations (20 µM curcumin + 10% DMSO, i.p. 20 min) and comparable light conditions (different light fluences from 5.28-26.4 J cm −2 , compared to 15.8 J cm −2 in the current study). For comparison, in our study, no antimicrobial effect was observed at 20 µM curcumin + 10% DMSO (i.p. 0, 5 or 25 min, see Figure 2 ). Interestingly, shorter incubation periods result in more pronounced photokilling of fungi, indicative of the limited stability of curcumin in aqueous solution influencing the photoantifungal effect.

By reducing the DMSO content to a final concentration of 0.5% (50 µM curcumin + 0.5% DMSO, i.p. 0 ) the relative inactivation was in the same order of magnitude (>4 log). Again, the phototoxic effect decreased with increasing incubation period before illumination. Reducing the concentration of DMSO in PDI using curcumin could prove beneficial, as DMSO has a broad spectrum of effects (e.g., anti-inflammatory or ROS scavenger) which could counteract photo treatment [39, 40] . Therefore, the influence of DMSO needs to be considered when applying the method in medicinal applications. In particular, DMSO could scavenge ROS generated by PDI.

When using the water-soluble curcumin derivate SA-CUR 12a as a photosensitizer, the supplementation of DMSO becomes obsolete. The photofungal effect against C. albicans (50 µM SA-CUR 12a, i.p. 0 or 5 min) was in the same order of magnitude (<4 log) as for curcumin. When the concentration of SA-CUR 12a was further increased to 100 µM (i.p. 5 or 25 min), maximal relative inactivation (>6 log steps) was induced.

Given the high photokilling efficiency of curcumin and SA-CUR 12a, PDI using these two substances is a promising alternative for the treatment of C. albicans infections. The use of curcumin in PDI against oral candidiasis has already been tested in immunosuppressed mice showing promising results (4 log reduction with treatment using 80 µM curcumin + 10% DMSO, 37.5 J cm −2 ) [41] . Additionally, first tests were performed on the clinical application of PDI for the treatment of oral candidiasis [37] using methylene blue as a photoactive compound. This approach induced a reduction of 1.99 log CFU of Candida spp. (mainly C. tropicalis and C. glabrata) after treatment of oral candidiasis in mechanically ventilated patients.

To provide insight into the potential of antifungal PDI in an environmental application, the model organism A. niger was used. This fungal species is also very interesting for comparison to Candida, as the experimental approach for determination of the photoantimicrobial effect is very different: viable spheres of A. niger with a diameter of 5 mm, thus representing tissue-like structures with the need for the diffusion of the photoactive compound into the mycelial patches, where exposed to curcumin or SA-CUR 12a at different concentration for 20 min and subsequently illuminated with light (15.8 J cm −2 ). The growth of colonies was monitored for 48 h. It was found that the treatment resulted in a significant decrease in colony size after illumination compared to the control samples. Fungal patches showing no increase in size were considered dead.

SA-CUR 12a was tested in three different concentrations (20, 50, 100 µM). To assess the influence of DMSO on the penetration of the PD into the spheres, experiments with or without 10% DMSO were performed. All combinations reduced the size of mycelial patches of A. niger after 48 h but did not completely inhibit the growth of the fungus. On the contrary, using curcumin as a PS increased the antifungal effect with a total growth inhibition using concentrations of 50 µM or 100 µM, both supplemented with 0.5% DMSO. Curcumin was found to show significant dark toxicity at 20 µM + 10% DMSO (p < 0.05) or 100 µM + 0.5% DMSO (p < 0.005). Figure 5 shows that in untreated controls the typical Aspergillus black conidia are formed after incubation on agar plates after 48 h. In contrast, if patches are treated with 100 µM SA-CUR 12a the growth rate is slowed down and fewer or no conidia are formed. If 100 µM curcumin + 0.5% DMSO is used as a photoactive agent, there is no growth of mycelia and no conidia formation.

PDI has already been used to treat A. niger in previous studies; the PS used were synthetic substances (charged corrosoles and conjugated polymers) which, in contrast to the viable colonies presented here, were used to treat conidia [35, 36] . Growth inhibition was observed when at least 5 µM PTP (polythiophene-porphyrin) and the illumination of 50 J cm −2 were used. The viability of A. niger was reduced to 15% with 20 µM PTP [36] . PDI with two different cationic corrosoles at much higher concentrations when compared to our study (1 mM PS incubated for three days with constant illumination of 9 mW cm −2 ) resulted in a complete growth arrest [35] . The use of curcumin could however prove to work as a very mild, cheap, biocompatible and eco-friendly alternative to synthetic photosensitizers.

Taking the presented work and the work from literature together, PDI should be considered as a novel strategy against fungal contamination in an environmental context but also in the food industry, as curcumin is approved as a food additive E100.

In conclusion, the results of using the novel PS SACUR-12a and natural curcumin in PDI treatment show multiple applications in clinical and industrial settings. As C. albicans and A. niger are culprits for several health problems in humans and the current treatment is expensive and leads to problems such as antimicrobial resistance or pulmonary diseases, the use of PDI seems to be a promising alternative.

The stock solution (100 mM) of curcumin (Carl Roth, Karlsruhe, >90.6%) was prepared by dissolving in DMSO (Fluka Analytical, Buchs, Switzerland). SACUR-12a [42] was kindly provided by Dr. Andreas Spaeth (Institute of Organic Chemistry, University of Regensburg, Regensburg, Germany). A stock solution (5 mM) of SACUR-12a was prepared in ddH 2 O. Both stock solutions were stored at −20 • C in the dark until use. The chemical structures of curcumin and SA-CUR 12a [42] are shown in Figure 10 . 

The overnight culture was diluted with SB media to absorption of 0.05 AU at 600 nm (Infinite M200, Tecan, Switzerland) and incubated for 4 h at 37 • C and 200 rpm to a final concentration of about 0.3 AU at 600 nm (corresponding to about 6.5 log CFU per 2 mL culture). For each treatment, 2 mL of the cultures were centrifuged at 830 rcf for 3 min (Centrifuge 5417R, Eppendorf, Hamburg, Germany). The supernatant was removed and the pellet was resuspended in 1 mL sterile filtered DPBS (Dulbecco's Phosphate Buffered Saline, Lonza Group, Verviers, Belgium) containing the different concentrations of the photosensitizer (10 µM, 50 µM or 100 µM SACUR-12a; 5 µM, 10 µM, 20 µM or 50 µM curcumin with 0.5% or 10% DMSO). Three controls were used for each experiment: C−/− (without PS and illumination), PS only (with PS at the highest concentration used in the experiment and no light), and light only (no PS, but with illumination). The samples were then incubated in the dark for different periods of time (0, 5 or 25 min). All control samples were incubated for 25 min. Subsequently, the samples and the light control were illuminated from below with a self-made LED array (435 nm, 15.8 J cm −2 ) under constant shaking (400 rpm) for 1 h. The C−/− and PS-only control were incubated under constant shaking (400 rpm) in the dark for 1 h. The samples were serially diluted in DPBS and plated on SB plates containing 1.5% Agar-Agar Kobe I (Carl Roth) and incubated for one day at 37 • C followed by counting the colony-forming unit (CFU). All experiments were repeated three times.

Taking the presented work and the work from literature together, PDI should be considered as a novel strategy against fungal contamination in an environmental context but also in the food industry, as curcumin is approved as a food additive E100.

In conclusion, the results of using the novel PS SACUR-12a and natural curcumin in PDI treatment show multiple applications in clinical and industrial settings. As C. albicans and A. niger are culprits for several health problems in humans and the current treatment is expensive and leads to problems such as antimicrobial resistance or pulmonary diseases, the use of PDI seems to be a promising alternative.

The stock solution (100 mM) of curcumin (Carl Roth, Karlsruhe, >90.6%) was prepared by dissolving in DMSO (Fluka Analytical, Buchs, Switzerland). SACUR-12a [42] was kindly provided by Dr. Andreas Spaeth (Institute of Organic Chemistry, University of Regensburg, Regensburg, Germany). A stock solution (5 mM) of SACUR-12a was prepared in ddH2O. Both stock solutions were stored at −20 °C in the dark until use. The chemical structures of curcumin and SA-CUR 12a [42] are shown in Figure 10 . 

Conidida from clinical isolates of Aspergillus niger, kindly provided by PD Dr. Tim Maisch (University Regensburg), were harvested using a sterile inoculation loop. The conidia were transferred to 20 mL SB media containing 0.2 mM Tween-20 (Carl Roth GmbH + CoKg) and incubated for two days at 37 • C in a 50 mL Greiner tube with constant shaking (200 rpm) (method adapted from [43] ). A total of 1 mL of the liquid culture was used to inoculate 30 mL of fresh SB media. This subculture was incubated for two days at 37 • C in a 50 mL Greiner tube with constant shaking (200 rpm) before being used for PDI.

Single colonies (sphere diameter: 5 mm) of A. niger were transferred to 500 µL of treatment solutions containing different concentrations of PS diluted in DBPS. Three controls were used for each experiment: C−/− (without a PS and illumination), PS control (with PS in the highest concentration used in the experiment and no light) and light control (illumination with the samples but without a PS). The samples were then incubated for 20 min in the dark at room temperature with constant shaking (400 rpm). Afterward, the samples, except for C−/− and PS control, were illuminated with an LED array (435 nm, 15.8 J cm −2 ) from below under constant shaking (400 rpm). The C−/− and the PS control were incubated under constant shaking in the dark for one hour using the same shaker as the samples. The colonies were then transferred to an SB agar plate containing 1.5% Agar-Agar Kobe I (for microbiology, Carl Roth GmbH + CoKg) and incubated for three days at 37 • C (adapted from [43] ).

Growth inhibition was investigated by imaging the cultures at different time points and measuring the colony area using the image processing and analyzing software Im-ageJ 1.48v (National Institute of Health, Bethesda, MD, USA [44] ). Each experiment was reproduced nine times.

Unless otherwise stated, data represent the mean with the corresponding error bars of standard deviation of the relative inactivation (C. albicans, n = 3) or the colony area (A. niger, n = 9). The relative inactivation was calculated by dividing the CFU of the corresponding C−/− by the CFU of the individual treatments. In the case of complete inactivation (CFU = 0) the CFU of the C−/− was divided by one [29] . The dashed line in the C. albicans plots represents a 3 log reduction, which marks the minimum reduction for an antimicrobial effect. Data analysis was performed using Excel (v2016, Microsoft, Redmond, WA, USA) and Matlab R2019a (MathWorks, Natick, MA, USA). Statistical analysis was performed using RStudio version 1.4 (Bosten, MA, USA) using the Mann-Whitney U test. Statistical significance was indicated with p < 0.05 (*), p < 0.005 (**), p < 0.001 (***). 

The data presented in this study are available within this article.

Candida albicans pathogenicity mechanisms

Changing epidemiology of systemic fungal infections

Emerging and reemerging fungal infections

Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens

New Horizons in Antifungal Therapy

Ten questions concerning occupant health in buildings during normal operations and extreme events including the COVID-19 pandemic

Photodynamic therapy for localized infections-State of the art

Antimicrobial photodynamic therapy to kill Gram-negative bacteria

Photodynamic Therapy of Microbial Infections: State of the Art and Perspectives

Photodynamic therapy for infections: Clinical applications

Effect of curcuminmediated photodynamic therapy on Streptococcus mutans and Candida albicans: A systematic review of in vitro studies

Antimicrobial photodynamic inactivation: A bright new technique to kill resistant microbes

Resistance in antimicrobial photodynamic inactivation of bacteria

Can microbial cells develop resistance to oxidative stress in antimicrobial photodynamic inactivation? Drug Resist

Population-Based Active Surveillance for Culture-Confirmed Candidemia-Four Sites

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Morphology and productivity of filamentous fungi

Mould growth in energy efficient buildings: Causes, health implications and strategies to mitigate the risk

The National Human Activity Pattern Survey (NHAPS): A resource for assessing exposure to environmental pollutants

Environmental Protection Agency Indoor Environments Devision. Mold Remediation in Schools and Commercial Buildings

US Department of Health and Human Services, Centres for Disease Control Prevention

Back to the roots: Photodynamic inactivation of bacteria based on water-soluble curcumin bound to polyvinylpyrrolidone as a photosensitizer

Spectral and photochemical properties of curcumin

Phototoxic effect of curcumin on methicillin-resistant Staphylococcus aureus and L929 fibroblasts

A novel photosensitization treatment for the inactivation of fungal spores and cells mediated by curcumin

Investigation of the photodynamic effects of curcumin against Candida albicans

New horizons in microbiological food safety: Photodynamic Decontamination based on a curcumin derivative

CureCuma-cationic curcuminoids with improved properties and enhanced antimicrobial photodynamic activity

Effects of Ionizing Radiation on Postharvest Fungal Pathogens

Candida auris: A Review of the Literature

Use of Disinfectants: Alcohol and Bleach. Infection Prevention and Control of Epidemic-and Pandemic-Prone Acute Respiratory Infections in Health Care; World Health Organization

Photodynamic inactivation of mold fungi spores by newly developed charged corroles

PDT technology: An alternative to control oral candidiasis in critically ill patients

In vitro study of photodynamic therapy with visible laser systems applied to fungal infections

Immunomodulatory effects and potential clinical applications of dimethyl sulfoxide

Multidisciplinary utilization of dimethyl sulfoxide: Pharmacological, cellular, and molecular aspects

Curcumin-mediated photodynamic inactivation of Candida albicans in a murine model of oral candidiasis

1,7-Diaryl-1,6-Heptadien-3,5-Dion-Derivate, Verfahren zur Herstellung und Verwendung Derselben

Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment

The authors are grateful to Andreas Spaeth, University of Regensburg for providing SA-CUR 12a and to Tim Maisch, University Medical Center Regensburg for providing A. niger. Further thanks go to Michael Glueck and Nicole Tortik for their support in the laboratory. We thank John W. C. Dunlop, Paris Lodron University of Salzburg for proofreading.

The authors declare no conflict of interest.

Treatment before and after Illumination 

Values represented in Figure 4 are including the following samples: